Rivaroxaban

Cat. No.: PI366789028

Description: In its finished dose formulation, Rivaroxaban is an oral anti-clotting substance (anticoagulant drug) which is used in the following instances: to prevent venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), in patients undergoing hip or knee replacement surgery; to prevent stroke and systemic embolism (in patients with atrial fibrillation); to treat DVT and PE and to reduce the risk of recurrent DVT and PE.

Product Details

CAS	366789-02-8
Trade Names	Xarelto
Synonyms	5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide.
Molecular Formula	C19H18CIN3O5S
Molecular Weight	435.89
Available Formulations	Oral Solid
Technology	Synthetic
Available DMF/CEP/GMP	CADIFA, CEP, EU DMF, Korea DMF, US DMF
Mechanism Of Action	Rivaroxaban API is a direct factor Xa inhibitor. Factor Xa is a protein involved in the clotting cascade. By blocking the activity of factor Xa, rivaroxaban API prevents the formation of blood clots.
Appearance	White to yellowish power

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Name *

Phone

Email *

Address *

Products & Service of Interest *

Project Description

Verification Code *